UBS Group
GTBP icon

UBS Group’s GT Biopharma GTBP Stock Holding History

UBS Group’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$35K Buy
+5,414
New +$43.8K ﹤0.01% 7958
2026
Q2 		– Sell
-1,839
Closed -$18.6K – 10383
2026
Q1 		$18.8K Buy
+1,839
New +$25.1K ﹤0.01% 7983
2025
Q4 		– Sell
-105
Closed -$1.86K – 10428
2025
Q3 		$1.54K Sell
105
-127
-55% -$4.74K ﹤0.01% 9322
2025
Q2 		$20.8K Buy
232
+130
+127% +$8.4K ﹤0.01% 8405
2025
Q1 		$5.5K Sell
102
-98
-49% -$5.76K ﹤0.01% 8984
2024
Q4 		$15.2K Buy
200
+44
+28% +$2.98K ﹤0.01% 8054
2024
Q3 		$9.01K Sell
156
-203
-57% -$12.1K ﹤0.01% 7806
2024
Q2 		$25.4K Buy
359
+318
+776% +$28.4K ﹤0.01% 7148
2024
Q1 		$4.53K Buy
41
+22
+116% +$2.91K ﹤0.01% 7614
2023
Q4 		$3.72K Buy
19
+7
+58% +$1.28K ﹤0.01% 7937
2023
Q3 		$2.11K Buy
12
+8
+200% +$1.65K ﹤0.01% 7767
2023
Q2 		$946 Sell
4
-6
-60% -$1.56K ﹤0.01% 8060
2023
Q1 		$4.29K Buy
10
+5
+100% +$2.86K ﹤0.01% 8208
2022
Q4 		$3.14K Buy
5
+1
+25% +$1.25K ﹤0.01% 9559
2022
Q3 		$5K Hold
4
– – ﹤0.01% 9195
2022
Q2 		$9K Sell
4
-2
-33% -$3.79K ﹤0.01% 8133
2022
Q1 		$13K Sell
6
-9
-60% -$19.8K ﹤0.01% 8048
2021
Q4 		$34K Buy
15
+9
+150% +$33.7K ﹤0.01% 7262
2021
Q3 		$32K Buy
6
+2
+50% +$15K ﹤0.01% 6692
2021
Q2 		$48K Sell
4
-1
-20% -$10.4K ﹤0.01% 6472
2021
Q1 		$27K Buy
+5
New +$21.8K ﹤0.01% 7094

Other funds holding GTBP

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Arax Advisory Partners
Arax Advisory Partners Denver, Colorado $17.7B AUM 20.22% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Main Street Group
Main Street Group Glen Allen, Virginia $445M AUM 22.95% 1-Year Est. Return
Newbridge Financial Services Group
Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
West Financial Advisors
West Financial Advisors Des Moines, Iowa $665M AUM 10.35% 1-Year Est. Return

UBS Group's GTBP Position: Q3 2026 in Review

UBS Group opened a new position in GT Biopharma (GTBP) in Q3 2026: 5,414 shares worth $35K. The stake represents ﹤0.01% of the portfolio and ranks #7958 among its holdings. This is a return to the name: UBS Group previously reported a position in GTBP as recently as Q1 2026.

UBS Group first reported a position in GTBP in Q1 2021 and has held it in 21 quarters since. The position peaked at $48K in Q2 2021. 17 funds tracked by Wall St. Rank hold GTBP as of Q3 2026.

  • UBS Group held 5,414 shares of GT Biopharma worth $35K as of Q3 2026.
  • GT Biopharma was a new UBS Group position in Q3 2026.
  • GT Biopharma made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #7958 holding.
  • UBS Group first reported a position in GT Biopharma in Q1 2021 and has held it in 21 quarters since.
  • UBS Group's GT Biopharma position peaked at $48K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held GT Biopharma as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.